Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models.
J Urol
; 191(1): 220-6, 2014 Jan.
Article
in En
| MEDLINE
| ID: mdl-23669563
Key words
AS; DRE; ECE; EPS; PCA3; PCR; PCa; PSA; TMPRSS2:ERG; TXNRD1; active surveillance; bodily secretions; digital rectal examination; expressed prostatic secretion; extracapsular extension; neoplasm staging; polymerase chain reaction; prostate; prostate cancer; prostate cancer antigen 3 (nonprotein coding); prostate specific antigen; prostatic neoplasms; qPCR; quantitative PCR; risk; thioredoxin reductase 1; transmembrane protease, serine 2 gene fusion with v-ets erythroblastosis virus E26 oncogene like (avian) gene
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostate
/
Prostatic Neoplasms
/
Biomarkers, Tumor
Type of study:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Urol
Year:
2014
Document type:
Article